Nancy Jean Cox to Schizophrenia
This is a "connection" page, showing publications Nancy Jean Cox has written about Schizophrenia.
Connection Strength
0.465
-
A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data. Nat Neurosci. 2019 05; 22(5):691-699.
Score: 0.133
-
Gene expression imputation across multiple brain regions provides insights into schizophrenia risk. Nat Genet. 2019 04; 51(4):659-674.
Score: 0.133
-
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5968-73.
Score: 0.094
-
Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet. 2006 Feb; 78(2):315-33.
Score: 0.053
-
Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes. Genome Med. 2021 10 29; 13(1):172.
Score: 0.040
-
Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol Psychiatry. 2004 Jul 01; 56(1):18-23.
Score: 0.012